For the second year, Team Noah members ran in the wide variety of race distances offered during Walt Disney World® Marathon Weekend presented by Cigna®.

Amber Larkin, Founder of Noah’s Light Foundation, received notification that the Food and Drug Administration (FDA) has granted The University of Texas MD Anderson Cancer Center approval to proceed with a new pediatric cancer treatment, called the NOAH Protocol. This investigative treatment aims at reducing and eliminating several types of pediatric brain cancer. The implications for groundbreaking results have not been achieved in over 30 years of research and development.

Please spread the word, or as we are now saying, #promotetheHOPE! Tell your friends, family & social media networks about the work we are doing to cure pediatric brain cancer and ask them to follow us, too! The more people who follow us